The annual change in SE and ocular biometry according to age, sex, SE, and AL at baseline is shown in
Table 2. The number of participants with available refractive or biometric data for each parameter is listed. There was a mean myopic shift of −0.47 D/y (95% CI, −0.51 to −0.43,
n = 643) across all age groups. Younger participants aged ≤20 years were significantly (two-sample
t test,
P < 0.001) more likely to become more myopic (−0.56 D/y; 95% CI, −0.60 to −0.51;
n = 405) than older participants aged >20 years (−0.32 D/y; 95% CI, −0.39 to −0.25;
n = 238). The largest myopic shifts were observed in those aged 7 to 10 years (−0.65 D/y; 95% CI, −0.82 to −0.48;
n = 39), with a gradual decline to the smallest myopic shift, which occurred in the 31- to 40-year age group (−0.24 D/y; 95% CI, −0.40 to −0.09;
n = 52). Beyond 40 years, the rate of myopic shift increased again, with the oldest group aged 51 to 70 years recording −0.53 D/y (95% CI, −0.78 to −0.29;
n = 27). A statistically significant (two-sample
t test,
P < 0.001) pattern was observed for annual AL change across the age groups, with greatest elongation observed in the younger participants ≤20 years (0.19 mm/y; 95% CI, 0.18 to 0.21;
n = 380), as compared with those aged >20 years (0.05 mm/y; 95% CI, 0.04 to 0.07;
n = 225). Overall, there was a mean increase in the LT (0.04 mm/y; 95% CI, 0.04 to 0.04,
n = 584), with a corresponding reduction in the ACD (−0.03 mm/y; 95% CI, −0.04 to −0.03,
n = 590). Axial elongation appeared to be largely attributable to an increase in the VCD (all-age means for annual change in AL and VCD were both 0.14 mm/y; 95% CI, 0.13 to 0.15), rather than changes in the ACD or LT. The results do not show any significant differences between males and females with regard to annual change in SE or ocular biometry (
P > 0.05 for all).